Skip to main content

News

February 08, 2020
Intraoperative molecular imaging used to illuminate and target non-small-cell lung cancer shows improved outcomes for 26% of patients in multi-institutional Phase 2 clinical trial. WEST LAFAYETTE, Ind.
June 15, 2018
Percutaneous cryoblation ablation may be a reasonable treatment option for patients with clinical stage T1a papillary on renal cell carcinoma (pRCC) and clear-cell RCC (ccRCC), especially for patients with (pRCC).
June 14, 2018
The combination of microwave ablation and cementoplasty may offer patients with extra-spinal metastases a minimally invasive option for pain reduction
June 12, 2018
Researchers hypothesized that inhibition of cancer stem cells in HCC may improve the efficacy of percutaneous thermal ablation, TACE, and TAE.
June 05, 2018
The researchers compared outcomes for patients undergoing RFA for primary left-side vs right-side colorectal cancer.
May 31, 2018
An analysis of 9 studies compared TACE plus iodine-125 seed with TACE alone for patients with HCC.
May 29, 2018
Use of TARE for HCC has been increasing over the past decade, according to a study published in JVIR.
May 22, 2018
Analysis of several pretreatment factors may help predict the prognosis of patients treated with Y-90 radioembolization for liver metastases from colorectal cancer.
May 17, 2018
Cryoablation offers an alternative for patients with cancer pain that cannot be controlled with medication. The authors of the current study undertook a review of the evidence surrounding cryoablation for pain control.
May 15, 2018
Investigators compared amounts of patient radiation exposure in transradial and transfemoral access.
May 08, 2018
The investigators assessed whether chemoembolization with polyethylene glycol (PEG) drug-eluting embolic agents is a safe and effective treatment for HCC.
Back to Top